Here’s the current breakdown of my five-stock portfolio:
$NVIDIA(NVDA)$ - 44%
Core AI infrastructure exposure, still the main driver of overall portfolio beta.
$NEBIUS(NBIS)$ - 24%
A high-growth AI/data center infrastructure play, offering more asymmetry but with higher volatility.
$Hims & Hers Health Inc.(HIMS)$ - 14%
A consumer healthcare component with a recurring revenue model, providing a more defensive growth element.
Offers exposure to the Southeast Asia platform economy, though it remains sensitive to macro factors and execution.
$UiPath(PATH)$ - 8%
An automation/software turnaround story. It's a smaller position, but offers optionality if their execution stabilizes.
Essentially, the portfolio is split between AI infrastructure leadership and a few higher-risk growth names with optionality. It's still heavily momentum-driven, but includes some diversification outside of semiconductors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
